𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of Trager therapy on the level of evoked stretch responses in patients with Parkinson's disease and rigidity

✍ Scribed by Christian Duval; Denis Lafontaine; Jacques Hébert; Alain Leroux; Michel Panisset; Jean P. Boucher

Book ID
117846113
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
225 KB
Volume
25
Category
Article
ISSN
0161-4754

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled pilot study of the effects of
Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease
✍ Lauren H. Craig; Anna Svircev; Michael Haber; Jorge L. Juncos 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract The objectives of this study is to examine the effects of neuromuscular therapy (NMT) on motor and nonmotor symptoms in Parkinson's disease (PD). Thirty‐six subjects with PD were randomly assigned to NMT or music relaxation (MR, or active control). Subjects received treatment twice a we

The effects of cisapride on plasma L-dop
The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease
✍ Walter Diaz Neira; Vicenta Sanchez; Maria Angeles Mena; Dr. Justo Garcia de Yebe 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

Cisapride (CIS) is a prokinetic agent that increases gastrointestinal motility in normal individuals and improves constipation in Parkinson's disease (PD). We studied the effects of CIS on the clinical response and the peripheral pharmacokinetics of orally administered L-dopa given to patients with

Effect of entacapone, a COMT inhibitor,
Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease
✍ V. V. Myllylä; K. A. Sotaniemi; A. Illi; K. Suominen; T. Keränen 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 563 KB

In an open, randomised, cross-over study we investigated the effect of a single 200 mg oral dose of entacapone, a novel catechol-O-methyltransferase (COMT) inhibitor, on the pharmacokinetics and metabolism of levodopa/carbidopa, and on the cardiovascular responses (blood pressure and pulse rate vari